SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001157523-16-007275
Filing Date
2016-11-07
Accepted
2016-11-07 07:40:18
Documents
2
Period of Report
2016-11-07
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.08: Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
Item 7.01: Regulation FD Disclosure
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 ARIAD PHARMACEUTICALS, INC. 8-K a51454967.htm 8-K 21851
2 EXHIBIT 99.1 a51454967ex99_1.htm EX-99.1 127585
  Complete submission text file 0001157523-16-007275.txt   150693
Mailing Address 26 LANDSDOWNE CAMBRIDGE MA 02139
Business Address 26 LANDSDOWNE ST CAMBRIDGE MA 02139 6174940400
ARIAD PHARMACEUTICALS INC (Filer) CIK: 0000884731 (see all company filings)

IRS No.: 223106987 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36172 | Film No.: 161976576
SIC: 2836 Biological Products, (No Diagnostic Substances)